The 602 people who were hospitalised due to an infection showed at the start of the study that they had fewer butyrate-producing bacteria in their microbiome. Butyrate is a small fatty acid that is known to have a positive impact on the immune system of mice. It has also been seen before that people with serious infections have less of these bacteria. "But we didn't know whether the less healthy gut flora is due to the acute infection and its treatment or whether they have always had less of the butyrate-producing bacteria in their microbiome," says PhD student Bob Kullberg. "The study now answers this chicken-and-egg question."
The researchers wanted to know whether, just like in mice, butyrate also has a beneficial effect on the immune system in humans. The study analysed stool samples from more than 10,000 people (6,000 from the Finnish FINRISKI cohort and more than 4,000 Dutch participants from the HELIUS cohort). In the study, the researchers analysed 16 bacteria that make butyrate druing the the fermentation of dietary fiber. Humans can't digest fiber on their own, but these bacteria can. The 602 patients who were hospitalised during the 6-year follow-up study had significantly fewer of these butyrate-producing bacteria in their gut compared to the remaining people in the 2 cohorts.
"We saw that in people who have 10% more of those bacteria in their gut, the chance of getting an infection decreases by as much as 15 to 25%," says Kullberg. Thus, the microbiome is involved in infections outside the gut, such as lung and bladder infections. The analyses considered factors such as age, history of antibiotic use, and underlying diseases that influence gut microbiota composition and infection risk.
Follow-up research
Butyrate thus improves the defence against infections outside the intestines. This finding emphasises the importance of a healthy microbiome and opens doors to predicting the risk of a serious infection for each individual. But why one individual has more butyrate-producing bacteria than the other remains a question.
The question of whether something can be done to introduce these bacteria into the intestines is also still unanswered. "Follow-up research is needed to find out how we can increase the amount of butyrate with diet or probiotics, in order to prevent serious infections," says co-researcher and professor Joost Wiersinga.
Read the full article in The Lancet Microbe.